Orthomolecular therapy: Its history and applicability to psychiatric disorders
- 101 Downloads
- 2 Citations
Abstract
Orthomolecular therapy has had much support and much opposition, and yet there remain a number of professionals and parents who continue the quest for its effective application in the amelioration of psychiatric disorders. The popular press has again been the forum for heated debate between those who debunk its possibilities and those who attest to its operative use. Because the parents of mentally retarded and mentally ill children are particularly vulnerable to the raising or dashing of their hopes against claims being made either way, this paper provides an overview and history of orthomolecular therapy, its application to both mental illness and mental retardation, as well as toxicity considerations relative to megavitamin treatment, in the hope that such information will provide mental health professionals with concise an swers to the challenging questions currently being asked by their patients.
Keywords
Mental Health Health Professional Mental Illness Psychiatric Disorder Social PsychologyPreview
Unable to display preview. Download preview PDF.
References
- 1.Olson RE, Broguist HP, Chichester CO, Darby WJ, Kolbye AC, & Stalvey RM:Nutrition reviews present knowledge in nutrition, (5th Edition). Washington, DC: The Nutrition Foundation, Inc, 1984.Google Scholar
- 2.Carpenter KJ:The History of Scurvy and Vitamin C. New York, Cambridge University Press, 1986.Google Scholar
- 3.Hillman RE: Megavitamin responsive aminoacidopathies.Pediatric Clinics of North America, 23(3), 557–567, 1976.Google Scholar
- 4.Fernhoff P, Lubitz D, Danner D, Dembure P, Schwartz H, Hillman R, Bier D, & Elsas L: Thiamine response in maple syrup urine disease.Pediatric Research, 19, 1011–1016, 1985.Google Scholar
- 5.Scriver C, Clow C, & George H: So-called thiamine-responsive maple syrup urine disease: 15-year follow-up of the original patient.The Journal of Pediatrics, 107(5), 763–765, 1985.Google Scholar
- 6.Hathcock J: Toxicity of vitamins for vitamin nutrition information service (VNIS)Vitamin Issues, 1, 1–6, 1985.Google Scholar
- 7.Food and Nutrition Board. National Research Council—National Academy of Sciences: Recommended dietary allowances: Scientific issues and process for the future.Journal of Nutrition, 116, 482–486, 1986.Google Scholar
- 8.Pauling L: Orthomolecular psychiatry.Science, 160, 265–271, 1968.Google Scholar
- 9.Kunin RA: Orthomolecular Psychiatry. In: R.P. Huemer (Ed.):The roots of molecular medicine. New York: W.H. Freeman Company, 1986.Google Scholar
- 10.Hoffer A, Osmond H, Callback J, & Kahan R: Treatment of schizophrenics with nicotine acid and nicotinamide.J Clin Exper Psychopath. 18, 131–158, 1957.Google Scholar
- 11.Hoffer A & Osmond H: Nicotinamide adenine dinucleotide (NAD) as a treatment for schizophrenia.Journal of Psychopharmacology, 1, 79–94, 1966.Google Scholar
- 12.Hoffer A: Orthomolecular therapy.Psychiatric Opinion, 10, 6, 1973.Google Scholar
- 13.Mosher LR: Nicotinic acid side affects and toxicity: A review:American Journal of Psychiatry, 126, 124–130, 1979.Google Scholar
- 14.American Psychiatric Association. Task Force on Orthomolecular Therapy.Psychiatric News, July, 1973.Google Scholar
- 15.Canadian Schizophrenic Foundation. Megavitamins in therapy.Reply to the American Psychiatric Association Task Force Report on Megavitamins and Orthomolecular Psychiatry. Regina, Saskatchewan, 1976.Google Scholar
- 16.Jukes TH: Megavitamin Therapy.Journal of the American Medical Association, 233, 550–551, 1975.Google Scholar
- 17.White P: Megavitamin this and megavitamin that.Journal of the American Medical Association, 233, 538–539, 1975.Google Scholar
- 18.Adler S: Behavior management: A nutritional approach to the behaviorally disordered and learning disabled child.Journal of Learning Disabilities, 11, 651–656, 1978.Google Scholar
- 19.Cott A: Orthomolecular approach to the treatment of learning disabilities.Schizophrenia, 3, 95–105, 1971.Google Scholar
- 20.Cott A: Megavitamins: The orthomolecular approach to behavioral disorders and learning disabilities.Academic Therapy, 7, 245–258, 1972.Google Scholar
- 21.Cott A: Treatment of learning disabilities.Journal of Orthomolecular Psychiatry, 3, 343–355, 1974.Google Scholar
- 22.Rimland B, Callaway E, & Dreyfus P: The effects of high doses of vitamin B6 on autistic children: A double-blind crossover study.American Journal of Psychiatry, 4(135), 472–475, 1978.Google Scholar
- 23.Rimland B: High dosage levels of certain vitamins in the treatment of children with severe mental disorders. In D. Hawkins and L. Pauling (Eds.),Orthomolecular psychiatry, New York: Freeman W.H., 1973Google Scholar
- 24.Rimland B: An orthomolecular study of psychotic children.Orthomolecular psychiatry, 3, 371–377, 1974.Google Scholar
- 25.Schmid F:Cytobiologishe revue, 1, 25–32, 1978.Google Scholar
- 26.Turkel H:New hope for the mentally retarded, New York: Vantage Press, 1972.Google Scholar
- 27.Turkel H: Medical amelioration of Down's syndrome incorporating the orthomolecular approach.The Journal of Orthomolecular Psychiatry, 4, 2. 102–115. 1975.Google Scholar
- 28.Turkel H: A treatment for mongolism stymied by the FDA.Prevention. 61–79, 1979.Google Scholar
- 29.Wunderlich R: Treatment of the hyperactive child.Academic Therapy, 8, 375–390, 1973.Google Scholar
- 30.Arnold L, Christopher J, Heustis R, & Smeltzer D: Megavitamins for minimal brain dysfunction: A placebo controlled study.Journal of the American Medical Association, 240, 2642–2643, 1978.Google Scholar
- 31.Bumbalo T, Morelevica H, & Bernas D: Treatment of Down's syndrome with the “U” series of drugs.Journal of the American Medical Association, 198, 125–131, 1964.Google Scholar
- 32.Kershner J & Gerkin R: A pilot study of a high-protein and high-vitamin, low carbohydrate, sugar-free diet with learning disabled children.Special education monograph, Toronto: Ontario Institute for Studies in Education, 1976.Google Scholar
- 33.Morgan DG: An overview of research at Walden House. Paper presented at Atlanta Regional Conference of the National Society for Autistic Children: Atlanta. GA. 1976.Google Scholar
- 34.Kershner J & Hawke W:Nutrition, 109, 819–826, 1979.Google Scholar
- 35.Harrell R, Capp R, Davis D, Peerless J, & Ravitz L: Can nutritional supplements help mentally retarded children? An exploratory study.Proc Nat'l Acad Sci USA, 78, 1, 574–578, 1981.Google Scholar
- 36.Williams RJ: Biochemical individuality: The basis for the genetotrophic concept. Austin: University of Texas Press, 1956.Google Scholar
- 37.Feingold BF: Hyperkinesis and learning disabilities linked to artificial food flavors and colors.American Journal of Nursing, 75, 5, 797–803, 1975.Google Scholar
- 38.Feingold BF: Hyperkinesis and learning disabilities linked to the ingestion of artificial food colors and flavors.Journal of Learning Disabilities, 9, 551–559, 1976.Google Scholar
- 39.Conners C, Goyette C, Southwick D, Lees J & Andrulonis P: Food additives and hyperkinesis: A controlled double-blind experiment.Pediatrics, 58, 154–166, 1976.Google Scholar
- 40.Snyder S, Baraban J & Worley P: Second messengers in brain function and psychiatry.Strecker Monograph Series, Number XXIII, 1986.Google Scholar